explored the involvement of miR‐125b in the progression of doxorubicin resistance in nucleophosmin‐anaplastic lymphoma kinase (NPM‐ALK) (+) anaplastic large‐cell lymphoma (ALCL). This evidence concerns the gene ALK and anaplastic large cell lymphoma.